Hongxia Liang

#1 Jianshe East Road
Zhengzhou, 450052, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Study of α-Amyrin targeting Sirt1/PGC-1α/PPARα axis to regulate fatty acid metabolism against liver fibrosis.

Study of α-Amyrin targeting Sirt1/PGC-1α/PPARα axis to regulate fatty acid metabolism against liver fibrosis.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: October 01, 2025

Lysosome-Targeting Nanochimeras Attenuating Liver Fibrosis by Interconnected Transforming Growth Factor-β Reduction and Activin Receptor-Like Kinase 5 Degradation.

Lysosome-Targeting Nanochimeras Attenuating Liver Fibrosis by Interconnected Transforming Growth Factor-β Reduction and Activin Receptor-Like Kinase 5 Degradation.

Journal: ACS nano

Published: July 12, 2025

Study on the anti-liver cirrhosis of Fuzheng Huayu tablet : Targeting macrophage PPARα axis-fatty acid metabolic.

Study on the anti-liver cirrhosis of Fuzheng Huayu tablet : Targeting macrophage PPARα axis-fatty acid metabolic.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: July 01, 2025

Real-world effectiveness and safety of oral azvudine versus Paxlovid in patients with COVID-19 and pre-existing hypertension: a multicentre, retrospective, cohort study in Henan Province, China.

Real-world effectiveness and safety of oral azvudine versus Paxlovid in patients with COVID-19 and pre-existing hypertension: a multicentre, retrospective, cohort study in Henan Province, China.

Journal: BMJ open

Published: June 27, 2025

Effectiveness of azvudine versus nirmatrelvir/ritonavir for hospitalized patients with SARS-CoV-2 infection and pre-existing liver diseases.

Effectiveness of azvudine versus nirmatrelvir/ritonavir for hospitalized patients with SARS-CoV-2 infection and pre-existing liver diseases.

Journal: Virology journal

Published: January 17, 2025

Efficacy and safety of azvudine versus nirmatrelvir/ritonavir in cancer patients with COVID-19.

Efficacy and safety of azvudine versus nirmatrelvir/ritonavir in cancer patients with COVID-19.

Journal: Scientific reports

Published: August 02, 2024

Effectiveness and Safety of Oral Azvudine for Elderly Hospitalized Patients With COVID-19: A Multicenter, Retrospective, Real-World Study.

Effectiveness and Safety of Oral Azvudine for Elderly Hospitalized Patients With COVID-19: A Multicenter, Retrospective, Real-World Study.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 25, 2024

Immune Dysregulation in SARS-CoV-2 patients coinfected with Mycobacterium tuberculosis (Mtb) or HIV in China.

Immune Dysregulation in SARS-CoV-2 patients coinfected with Mycobacterium tuberculosis (Mtb) or HIV in China.

Journal: BMC public health

Published: August 25, 2023

The role and mechanism of hydrogen sulfide in liver fibrosis.

The role and mechanism of hydrogen sulfide in liver fibrosis.

Journal: Nitric oxide : biology and chemistry

Published: August 21, 2023

Oral Microbiome Characteristics in Patients With Autoimmune Hepatitis.

Oral Microbiome Characteristics in Patients With Autoimmune Hepatitis.

Journal: Frontiers in cellular and infection microbiology

Published: January 29, 2021

MicroRNA-638 induces apoptosis and autophagy in human liver cancer cells by targeting enhancer of zeste homolog 2 (EZH2).

MicroRNA-638 induces apoptosis and autophagy in human liver cancer cells by targeting enhancer of zeste homolog 2 (EZH2).

Journal: Environmental toxicology and pharmacology

Published: August 21, 2020

Characteristic of 523 COVID-19 in Henan Province and a Death Prediction Model.

Characteristic of 523 COVID-19 in Henan Province and a Death Prediction Model.

Journal: Frontiers in public health

Published: May 15, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026